首页> 外文期刊>BMC Ophthalmology >A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal
【24h】

A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal

机译:玻璃体切除术治疗慢性肾脏病严重玻璃体视网膜病变的临床分析

获取原文
           

摘要

The recent advancement in the management of chronic renal failure (CRF) has significantly increased the longevity of the patients, which increase the incidence of severe vitreoretinopathy. The vitrectomy is highly risky in this particular group of patients due to their systemic comorbidity. The timing surgical intervention is usually delayed because of the systemic conditions. This study is to evaluate the safety and effectiveness of 25-guage vitrectomy for severe vitreoretinopathy in the CRF patients. In this retrospective study, 16 eyes of 16 CRF patients with severe vitreoretinopathy were undergone 25-guage vitrectomy in the department of Ophthalmology of the Second Hospital of Tianjin Medical University from February 2015 to April 2017. The visual outcome, complications and perioperative medical management were documented and analyzed. The best-corrected visual acuity(BCVA)of fourteen eyes were lower than 20/200 preoperatively. Surgery duration ranged from 28 to 72?min, with a mean of 48.4?±?13.6?min. During the surgery, 12 eyes were diagnosed with DR, while two them were complicated with tractional retinal detachment and one with branch retinal vein occlusion. Three eyes were diagnosed with branch retinal vein occlusion, and one eye was diagnosed with hypertensive retinopathy. Postoperative BCVA of six eyes ≥20/40, seven eyes ≥20/200, and three eyes
机译:慢性肾衰竭(CRF)管理的最新进展显着提高了患者的寿命,从而增加了严重玻璃体视网膜病变的发生率。由于他们的全身合并症,玻璃体切除术在这组特定的患者中具有很高的风险。由于全身情况,通常会推迟手术时间。这项研究旨在评估25例玻璃体切除术对CRF患者的严重玻璃体视网膜病变的安全性和有效性。这项回顾性研究于2015年2月至2017年4月在天津医科大学第二医院眼科对16例CRF严重玻璃体视网膜病变患者的16眼进行了25眼玻璃体切除术。记录和分析。术前14只眼的最佳矫正视力(BCVA)低于20/200。手术时间从28到72分钟不等,平均为48.4±13.6分钟。手术期间,诊断出12眼患有DR,其中2眼伴有牵引性视网膜脱离并伴有视网膜分支静脉阻塞。三只眼被诊断为视网膜分支静脉阻塞,另一只眼被诊断为高血压视网膜病变。六眼≥20/ 40,七眼≥20/ 200,三眼<≥20/ 200的术后BCVA。八只眼的BCVA改善了三行以上,三只眼改善了两行,四只眼改善了一条线。一名在手术后两周出现新血管性青光眼的患者中,BCVA从手部运动降低到光线感知。对于患有严重玻璃体视网膜病变的慢性肾衰竭患者,精心计划的微创玻璃体切除术是安全有效的。此外,围手术期全身状况的仔细管理对于改善视敏度和生活质量也很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号